Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 20

    1.

    Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.

    Wand H, Spiegelman D, Law M, Jalaludin B, Kaldor J, Maher L.

    Addiction. 2009 Dec;104(12):2049-56. Epub 2009 Oct 5.PMID: 19804463 [PubMed - in process]Related articles

    2.

    Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial.

    Read TR, Carey D, Mallon P, Mijch A, Goodall R, Hudson F, Wand H, Emery S.

    AIDS. 2009 Oct 23;23(16):2222-3.PMID: 19773634 [PubMed - in process]Related articles

    3.

    Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method.

    Wand H, Wilson D, Yan P, Gonnermann A, McDonald A, Kaldor J, Law M.

    J Int AIDS Soc. 2009 Sep 18;12(1):19.PMID: 19761622 [PubMed - in process]Related articlesFree article

    4.

    Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.

    Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A.

    Curr HIV Res. 2009 Jul;7(4):454-61.PMID: 19601783 [PubMed - indexed for MEDLINE]Related articles

    5.

    Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.

    Nakhaee F, Black D, Wand H, McDonald A, Law M.

    Sex Health. 2009 Jun;6(2):129-34.PMID: 19457292 [PubMed - indexed for MEDLINE]Related articles

    6.

    Perinatal exposure to HIV among children born in Australia, 1982-2006.

    McDonald AM, Zurynski YA, Wand HC, Giles ML, Elliott EJ, Ziegler JB, Kaldor JM.

    Med J Aust. 2009 Apr 20;190(8):416-20.PMID: 19374612 [PubMed - indexed for MEDLINE]Related articles

    7.

    A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.

    Chen MY, Millwood IY, Wand H, Poynten M, Law M, Kaldor JM, Wesselingh S, Price CF, Clark LJ, Paull JR, Fairley CK.

    J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):375-80.PMID: 19214122 [PubMed - indexed for MEDLINE]Related articles

    8.

    Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster.

    Klug GM, Wand H, Boyd A, Law M, Whyte S, Kaldor J, Masters CL, Collins S.

    Brain. 2009 Feb;132(Pt 2):493-501. Epub 2008 Nov 28.PMID: 19042933 [PubMed - indexed for MEDLINE]Related articles

    9.

    Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.

    Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L; Collaboration of Australian Needle Syringe Programs.

    J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):632-8.PMID: 18491422 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

    Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee.

    AIDS. 2007 Nov 30;21(18):2445-53.PMID: 18025881 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.

    Maher L, Li J, Jalaludin B, Wand H, Jayasuriya R, Dixon D, Kaldor JM.

    Drug Alcohol Depend. 2007 Jul 10;89(2-3):244-50. Epub 2007 Feb 7.PMID: 17289299 [PubMed - indexed for MEDLINE]Related articles

    13.

    Who declines to give a name at a sexual health service?

    Spillane HC, McNulty AM, Wand H, Tribe K, Donovan B.

    Sex Transm Infect. 2007 Apr;83(2):160-2. Epub 2006 Nov 15.PMID: 17108006 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study.

    Youle M, Emery S, Fisher M, Nelson M, Fosdick L, Janossy G, Loveday C, Sullivan A, Herzmann C, Wand H, Davey RT Jr, Johnson MA, Tavel JA, Lane HC.

    PLoS Clin Trials. 2006 May;1(1):e3. Epub 2006 May 19. Erratum in: PLoS Clin Trials. 2007 May;2(5):e23. PMID: 16871325 [PubMed]Related articlesFree article

    15.

    A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

    Kelleher AD, Puls RL, Bebbington M, Boyle D, Ffrench R, Kent SJ, Kippax S, Purcell DF, Thomson S, Wand H, Cooper DA, Emery S.

    AIDS. 2006 Jan 9;20(2):294-7.PMID: 16511428 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial.

    Carey D, Wand H, Martin A, Rothwell S, Emery S, Cooper DA, Carr A; for the Rosey Investigators.

    AIDS. 2005 Aug 12;19(12):1325-7.PMID: 16052090 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.

    Kovacic JC, Martin A, Carey D, Wand H, Mallon PW, Feneley MP, Emery S, Cooper DA, Carr A; ROSEY Investigators.

    Antivir Ther. 2005;10(1):135-43.PMID: 15751771 [PubMed - indexed for MEDLINE]Related articles

    18.

    Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.

    Mallon PW, Wand H, Law M, Miller J, Cooper DA, Carr A; HIV Lipodystrophy Case Definition Study; Australian Lipodystrophy Prevalence Survey Investigators.

    J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):156-62.PMID: 15671800 [PubMed - indexed for MEDLINE]Related articles

    19.

    No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

    Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA; Rosey investigators.

    Lancet. 2004 Feb 7;363(9407):429-38.PMID: 14962523 [PubMed - indexed for MEDLINE]Related articles

    20.

    Physical activity, body mass index, and ovulatory disorder infertility.

    Rich-Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, Willett WC, Wand H, Manson JE.

    Epidemiology. 2002 Mar;13(2):184-90.PMID: 11880759 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...